StemRIM

Tokyo Stock Exchange 4599.T

StemRIM Share Price on January 30, 2025: USD 2.09

StemRIM Share Price is USD 2.09 on January 30, 2025, a -43.76% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

StemRIM 52-week high Share Price is USD 3.93 on February 28, 2024, which is 88.13% above the current Share Price.
StemRIM 52-week low Share Price is USD 1.82 on December 26, 2024, which is -12.87% below the current Share Price.
StemRIM average Share Price for the last 52 weeks is USD 2.77.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

Tokyo Stock Exchange: 4599.T

StemRIM

CEO	Mr. Masatsune Okajima
IPO Date	Aug. 9, 2019
Location	Japan
Headquarters	Saito Bio-Incubator
Employees	45
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals

Description

StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.

Key trends

Past 5 years